The relationship between periodontal diseases and inflammatory conditions, diabetes, and cardiovascular diseases is well explicated. SLE and periodontitis are both inflammatory diseases that affect the immune system (
34-
36). B lymphocyte plays a significant role in the development of SLE and periodontitis. Moreover, an increased level of IgG2, a subgroup of IgGs, has been observed in lupus and periodontitis (
37,
38). Many case studies have demonstrated the association between periodontal disease and lupus (
36,
39,
40). Based on the findings of the present study, of the 40 patients studied, 3 were males, and 37 were females. These findings are in agreement with those of Rees et al.’s study (
41), which indicates a range of 2: 1 to 9: 1 ratio of lupus incidence in females compared to males.
The mean age was 35.9 ± 11.2 years in the intervention group, and it was 42.8 ± 11.1 years in the control group. This age range of lupus incidence corresponds with the range defined in Burket as a reference source. Burket reports the highest age of lupus incidence from 20 to 40 years (
42).
Based on the results of the present study, the mean O'Leary plaque index score in the intervention group showed a significant decrease after the intervention compared to baseline, while there was no significant decrease in the control group. This difference indicates the effectiveness of the intervention in reducing dental plaques of patients present in the intervention group. Amiri et al. also reported that the preventive health education program improved oral hygiene indices, including the plaque index (
43). According to the findings of the present study, the mean OPI index score in both the control and intervention groups was 83.6 at baseline. An OPI score above 70% indicates poor oral health (
33). Fernandes et al.’s study, which examined the oral health and masticatory system in juvenile patients with SLE, reported poorer oral health and higher prevalence rates of gingivitis and jaw disorders in this group of patients, which is in agreement with the results of the present study (
44).
The results of this study showed that there was a significant decrease in the mean ESR index score after 3 months of intervention in both groups. This decrease in ESR is justifiable in both groups, given the fact that patients with SLE are treated with anti-inflammatory drugs. In the present study, the difference between the mean ESR reductions in the two groups was not statistically significant. Investigating the effect of periodontitis treatment on improving the efficacy of immunosuppressive therapy in patients with SLE, Fabbri et al.’s study showed that periodontal treatment slightly decreased ESR after 3 months. However, the reduction was significant in our study. In Fabbri’s study, the ESR index score showed a significant decrease after six months of treatment compared to the control group. In comparison to the results of our study, this finding may suggest the effect of the time factor on the effectiveness of health intervention on inflammatory factors such as ESR (
31). In Al-Katma et al.’s study (
37), the ESR index score in the group receiving health education and dental plaque removal increased by 76.4%, while only the improvement rate was 16.7% in the control group. The reduction in both groups is in line with the findings of the current study. In Al-Katma et al.’s study, there was a significant difference between the two groups in terms of ESR after 8 weeks, indicating the significant effect of dental plaque removal on ESR improvement. In this regard, the percentage is not consistent with our findings. Given that the lack of dental plaque was an inclusion criterion in the present study, the patients did not need to have plaque removal but only received health education. On the other hand, the time duration considered for the impact of the intervention was longer than that of Al-Katma et al.’s study.
The results of the present study show that the CRP index significantly decreased in both study groups, but there was no statistically significant difference between the groups. This result is in contrast to the results of Fabbri et al.’s study (
31), in which CRP was reduced only slightly after dental plaque treatment and health education. Also, in D'Aiuto et al.’s study on patients with rheumatoid arthritis (RA), there was a significant decrease in CRP and interleukin-6 only in the periodontal disease management group after two months from plaque removal and plaque control (
45), which does not correspond with our findings. Calderaro et al. (
46) performed a systematic study concerning the effect of periodontal treatment of RA. In all four case-control studies included in this systematic study, the control and intervention groups were followed at six weeks, eight weeks, and six months after the periodontal treatment. Periodontal treatment included plaque removal, root planning, and health education. The results of this study showed that DAS28 decreased in the intervention group, whereas CRP and ESR showed no significant change, which is similar to the results obtained in the present study.
The non-significant difference found in this study between the two groups in terms of reduction in ESR and CRP could be due to the intake of corticosteroid drugs by patients with SLE. These drugs can improve inflammation laboratory markers in patients (
47). Al-Mutairi et al. study showed that peritoneal dialysis (PD) in patients with lupus flare-up was significantly lower than in patients with a stable status to justify the finding on the ground that patients with lupus flare-up take increased drug doses, leading to greater control of inflammation and subsequent control of periodontal diseases. In the present study, both study groups were treated with the same doses of medication, and this may be the reason underlying the lack of difference in the extent to which ESR and CRP were reduced in the two groups (
48). The results of this study showed that the dsDNA index decreased significantly in both groups after the intervention; however, the difference was not significant between the two groups.
The results of the present study revealed a significant decrease in the mean SLE-DAI in both groups after the intervention. Nevertheless, between-group differences were not significant. After 3 months of non-surgical periodontal treatment, Fabbri et al. (
31) reported a significant decrease in the SLE-DAI in the intervention group, which is inconsistent with the results of the present study. Since in both of these studies, lack of dental plaque was an inclusion criterion, and the patients received only health education, the different sample sizes and the methods employed in these two studies may underlie the difference between the studies. Areas et al.'s study, suggests that some inflammatory cytokines are present in lupus and periodontal diseases, including IL-18, which is also associated with SLE-DAI and periodontal parameters (
49). Moreover, several studies (
32,
37,
41) have demonstrated the impact of periodontal diseases on the therapeutic pathway of SLE and RA diseases. However, the results of the present study did not show a significant relationship between health education intervention and SLE-DAI as an indicator of the severity of lupus disease.
By controlling the effect of patient performance on ESR, CRP, dsDNA, and SLE-DAI, the covariance analysis showed that the oral health education intervention had a significant effect on ESR, with an effect size of 9.6%. The educational intervention was effective on CRP, dsDNA, and SLE-DAI (effect sizes of 0.6%, 0.3%, and 7.1%, respectively); however, the effects were not significant. These results indicate that oral health education had a significant impact on controlling the ESR factor and, consequently, leading to disease management in patients with SLE. Patients with lupus experience higher severity of periodontal disease due to decreased salivary secretion, dry mouth, and subsequently reduced antibacterial effect of saliva (
18). Under these conditions, opportunistic microorganisms such as porphyromonas gingivalis (PG) can cause periodontal diseases. Also, gingivitis is more common and severe in individuals with immune defects due to the use of immunosuppressive drugs and chronic diseases such as lupus (
50). In patients who do not have dental plaque and do not need scaling, oral flora, such as PG, can reduce with oral and dental hygiene training, where inflammatory pathways can be controlled. Since one of the causes of SLE flare-ups is the activation of these inflammatory pathways (
51), health education can have a positive impact on SLE disease control. Also, based on the results of the present study and relying on the results of covariance analysis, this study demonstrated that the educational intervention had a significant impact on the ESR index in patients with lupus, which can make the lupus disease more controlled in these patients.
According to the small sample size in this study, the results may not represent the whole population. Therefore, it is advisable to conduct a similar study with a larger sample size. Also, given the type of intervention employed in this study, it is suggestible to consider longer-term follow-ups to study the effect of oral health education more closely.
5.1. Conclusions
After the effect of the patient performance was controlled, the study found that the educational intervention affected the most substantial change in the ESR index (effect size: 9.6%) and had the least effect on the dsDNA index. In both groups, the dsDNA index decreased after the intervention, although the difference between the groups was not significant. After 3 months, CRP did not show a significant decrease in this study. Also, the OPI index in the intervention group revealed a significant decrease after the intervention, indicating the positive effect of the intervention on reducing plaque index. Therefore, given the significant impact that the intervention had on the ESR index as well as the affordability and low cost of health education, it can be recommended to attempt to inform all patients with lupus about oral hygiene/health.